Testopel and Profen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Testopel (testosterone) and Profen (ibuprofen). Common drug interactions include implant site induration among females and blood alkaline phosphatase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Testopel and Profen. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Testopel?

Testopel has active ingredients of testosterone. eHealthMe is studying from 1,881 Testopel users. Check the latest studies of Testopel.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.



On Jul, 21, 2026

16 people who take Testopel and Profen together, and have interactions are studied.

Testopel and Profen drug interactions.

What are the common drug interactions of Testopel and Profen, by gender? *:

female:

  1. Implant site induration
  2. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  3. Anxiety
  4. Blood pressure increased
  5. Delusion (a false belief or opinion)
  6. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)

male:

  1. Blood alkaline phosphatase increased
  2. Blood triglycerides increased
  3. Arthralgia (joint pain)
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Diastolic dysfunction
  6. Fatigue (feeling of tiredness)
  7. Lung disorder (lung disease)
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Implant site erythema (redness at implant site)
  10. Injury

What are the common drug interactions of Testopel and Profen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Emotional distress
  2. Implant site induration
  3. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  4. Implant site erythema (redness at implant site)
  5. Injury
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Wound
  8. Arthralgia (joint pain)
  9. Bone density decreased
  10. Bone loss

50-59:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Diastolic dysfunction
  3. Lung disorder (lung disease)
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Anxiety
  6. Blood pressure increased
  7. Delusion (a false belief or opinion)

60+:

  1. Blood alkaline phosphatase increased
  2. Blood triglycerides increased
  3. Affect lability (emotional incontinence)
  4. Arthralgia (joint pain)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  7. Cardiac arrest
  8. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  9. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  10. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)

What are the existing conditions these people have? *

  1. Blood Testosterone Decreased: 4 people, 25.00%
  2. Gout (uric acid crystals building up in the body): 3 people, 18.75%
  3. Primary Myelofibrosis (primary disorder of the bone marrow): 3 people, 18.75%
  4. Laxative Supportive Care: 3 people, 18.75%
  5. Bronchial Disorder: 3 people, 18.75%
  6. Cardiac Disorder: 3 people, 18.75%
  7. Cardiac Failure Chronic: 3 people, 18.75%
  8. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 18.75%
  9. Diabetes: 2 people, 12.50%
  10. Back Pain: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Testopel and Profen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Testopel and Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Testopel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Testopel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Profen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on testosterone and ibuprofen (the active ingredients of Testopel and Profen, respectively), and Testopel and Profen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: